Trulieve Cannabis Corp.
TRLV | NYSE
$10.28
-$0.32 (-3.02%)
At close: Oct 30, 2026, 4:00 PM ET
$10.45
+$0.17 (+1.62%)
Pre-market:
Nov 2, 2026, 8:10 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Cash & Equivalents | 255.54M |
Short-Term Investments | n/a |
Long-Term Investments | n/a |
Other Long-Term Assets | 12.38M |
Receivables | 20.2M |
Inventory | 242.3M |
Other Current Assets | 26.36M |
Total Current Assets | 562.72M |
Property-Plant & Equipment | 838.74M |
Goodwill & Intangibles | 1.28B |
Total Long-Term Assets | 2.13B |
Total Assets | 2.7B |
Account Payables | 26.78M |
Deferred Revenue | 9.59M |
Short-Term Debt | 4.08M |
Other Current Liabilities | 25.73M |
Total Current Liabilities | 126.95M |
Long-Term Debt | 227.58M |
Other Long-Term Liabilities | 714.77M |
Total Long-Term Liabilities | 1.43B |
Total Liabilities | 1.55B |
Total Debt | 563.62M |
Book Value | 1.14B |
Book Value Per Share | 5.97 |
Common Stock | n/a |
Retained Earnings | -912.13M |
Comprehensive Income | n/a |
Shareholders Equity | 1.16B |
Total Investments | n/a |
Add to Watchlist
Select watchlists to add or remove TRLV